DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Activase (Alteplase) - Adverse Event Reports - Death - Asthma

 



Index of reports > Cases resulting in death (39) > Cases with Asthma (2)

Below is the selection of adverse event reports related to Activase (Alteplase) that includes cases resulting in death where reactions include asthma.

Adverse event in 74 year old female receiving Activase (Alteplase)

Reported by a physician from Japan on 2007-07-23

Patient: 74 year old female

Adverse reactions / side effects: Asthma, Tracheal Stenosis, Haemorrhagic Cerebral Infarction

Adverse event resulted in: death

Suspect drug(s):
Activase
    Dosage: 36 mg/60 kg iv
    Indication: Cerebral Artery Embolism
    Start date: 2007-04-10
    End date: 2007-04-10

Ticlopidine Hydrochloride
    Administration route: Oral
    Indication: Anticoagulant Therapy

Other drugs received by patient: Dextran 40-Lactated Ringer's Solution; Zantac 150; Radicut; Digoxin; Glyceol



Adverse event in 74 year old female receiving Activase (Alteplase)

Reported by a physician from Japan on 2007-07-09

Patient: 74 year old female

Adverse reactions / side effects: Asthma, Tracheal Stenosis, Haemorrhagic Cerebral Infarction

Adverse event resulted in: death

Suspect drug(s):
Activase (Alteplase)

Other drugs received by patient: Dextran 40-Lactated Ringer's Solution; Zantac; Radicut; Digoxin; Glyceol

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009